Connect with NCQA

twitter linkedin facebook google+ youtube pinterest

Report an Error

Use NCQA’s Feedback Form to report a broken link, or content error.

Annual Monitoring for Patients on Persistent Medications

This HEDIS Measure

Assesses adults 18 years and older who received at least 180 treatment days of ambulatory medication therapy for a select therapeutic agent during the measurement year and received at least one therapeutic monitoring event for the therapeutic agent in the measurement year:

  • Annual monitoring for members on angiotensin converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARB).
  • Annual monitoring for members on digoxin.
  • Annual monitoring for members on diuretics.
  • Total rate (sum of the three numerators divided by the sum of the three denominators).

So What?

Adverse drug events cause more than 700,000 visits to the ER each year.1 The more medications people take, the higher their risk of having an adverse drug event.1 Adverse drug events contribute to patient injury and increased health care costs. For patients on persistent medications, appropriate monitoring can reduce the occurrence of preventable adverse drug events.

References:

1.      Centers for Disease Control and Prevention. 2012. “Adults and Older Adult Adverse Drug Events.” http://www.cdc.gov/MedicationSafety/Adult_AdverseDrugEvents.html

tables
Monitoring for Patients Using ACE Inhibitors or ARBS
  Commercial Medicaid Medicare
Year HMO PPO HMO HMO PPO
2016 83.9 82.1 88.1 92.5 92.1
2015 83.7 81.0 87.5 92.6 91.9
2014 83.3 80.7 87.2 91.8 91.5
2013 83.3 80.4 87.9 92.2 91.9
2012 82.9 79.2 86.3 92.0 91.6
2011 82.5 78.8 85.9 91.3 91.4
2010 81.6 78.4 86.0 90.7 90.8
2009 80.8 77.6 85.9 89.6 89.8
2008 79.4 76.4 84.8 86.7 88.8
2007 77.2 75.6 82.5 84.8 87.8
2006 74.8 66.3 79.9 82.7 83.9
Monitoring for Patients Using Digoxin
  Commercial Medicaid Medicare
Year HMO PPO HMO HMO PPO
2016 48.0 38.6 54.6 57.0 54.2
2015 44.4 38.3 54.1 56.9 52.7
2014 44.4 37.7 54.0 54.5 55.6
2013 86.5 82.3 91.2 94.7 93.8
2012 86.5 80.6 90.2 94.5 93.2
2011 85.4 79.2 90.3 93.4 93.2
2010 84.6 79.1 89.7 93.1 92.7
2009 83.6 77.9 88.9 92.0 92.2
2008 81.9 76.6 88.5 90.4 91.1
2007 79.7 75.7 84.9 87.9 90.4
2006 77.3 64.2 83.0 86.2 87.1
Monitoring for Patients Using Diuretics
  Commercial Medicaid Medicare
Year HMO PPO HMO HMO PPO
2016 83.1 81.3 87.9 93.0 92.6
2015 83.1 80.5 87.5 93.0 92.4
2014 82.7 80.2 86.9 92.2 92.1
2013 82.9 79.9 87.9 92.7 92.3
2012 82.5 78.7 86.0 92.2 91.9
2011 82.1 78.4 85.4 91.6 91.8
2010 81.0 78.1 85.5 90.9 91.2
2009 80.4 77.2 85.4 89.8 90.3
2008 79.1 76.1 84.2 87.1 89.1
2007 76.8 75.2 81.3 84.8 87.6
2006 74.4 65.7 79.1 83.0 84.1
Monitoring for Patients on Combined Persistent Medications
  Commercial Medicaid Medicare
Year HMO PPO HMO HMO PPO
2016 83.5 81.6 87.7 92.2 91.9
2015 83.2 80.5 87.3 91.9 91.5
2014 82.9 80.3 86.8 91.1 91.1
2013 82.7 79.8 86.0 91.6 91.5
2012 82.3 78.5 84.5 91.4 91.3
2011 81.9 78.2 83.9 90.9 91.2
2010 80.9 77.8 83.9 90.2 90.6
2009 80.3 77.0 83.2 89.2 89.7
2008 78.9 75.8 82.6 86.3 88.6
2007 76.6 74.9 80.1 84.3 87.2
2006 74.3 65.6 77.7 82.2 83.6